Trial of Methylphenidate and Thioridazine
A double-blind, placebo-controlled, cross-over study of methylphenidate (0.4 mg/kg/day) and thioridazine (1.75 mg/kg/day) in 27 intellectually subaverage children is reported from The Nisonger Center for Mental Retardation and Developmental Disabilities, Ohio State Univ., Columbus, OH, and the Unive...
Saved in:
| Main Author: | |
|---|---|
| Format: | Book |
| Published: |
Pediatric Neurology Briefs Publishers,
1991-09-01T00:00:00Z.
|
| Subjects: | |
| Online Access: | Connect to this object online. |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Summary: | A double-blind, placebo-controlled, cross-over study of methylphenidate (0.4 mg/kg/day) and thioridazine (1.75 mg/kg/day) in 27 intellectually subaverage children is reported from The Nisonger Center for Mental Retardation and Developmental Disabilities, Ohio State Univ., Columbus, OH, and the University of Aukland, New Zealand. |
|---|---|
| Item Description: | 1043-3155 2166-6482 10.15844/pedneurbriefs-5-9-11 |